Medium Risk
Some ambiguity present. Human review recommended before large positions.
Moderate rule clarity (58/100). The market is generally well-structured with solid time clarity and outcome definition. Note: No explicit resolution source URL or reference provided. Ambiguity is limited but traders should review the full resolution criteria before trading.
Six weighted criteria
Time Clarity
How clearly the resolution deadline and time parameters are defined.
Resolution timeline is explicitly defined with a specific date and time reference.
20/20
Resolution Source
Whether an authoritative, verifiable data source is named.
Resolution source is absent or relies on vague, unverifiable references.
4/20
Outcome Definition
How precisely the YES/NO resolution conditions are specified.
Outcome conditions are precisely defined with explicit YES/NO resolution criteria.
18/20
Evidence Standard
Whether acceptable and excluded evidence types are documented.
Evidence standards are implied by context but not formally defined.
5/15
Edge Case Handling
Coverage of delays, revisions, cancellations, and disputed data.
Basic edge cases may be implied but are not explicitly documented in the rules.
5/15
Post-Trade Risk
Risk of retroactive re-interpretation after the market closes.
Moderate post-trade risk — some resolution criteria could be interpreted differently.
6/10
How this market settles
No on-chain dispute record available
Polymarket markets resolve via the UMA Optimistic Oracle on Polygon. The Gamma API did not return dispute metadata for this market, so no challenge history can be confirmed here.
Volume
$178K
24h Change
—
Liquidity
$4K
24h Volume
—
End Date
December 31, 2026 at 12:00 AM UTC
Resolution Source
Not specifiedDescription
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Same category or risk level
Outcomes
Will Bitcoin reach $90,000 in June?
